Condition
Non Union Fracture
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Early P 1 (1)
P 1 (1)
P 3 (1)
Trial Status
Unknown3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03325504Phase 3CompletedPrimary
A Comparative Study of 2 Doses of BM Autologous H-MSC+Biomaterial vs Iliac Crest AutoGraft for Bone Healing in Non-Union
NCT06103396Phase 1Unknown
Treatment of Nonunion Fractures With Mesenchymal Stromal Cells (MSCs)
NCT04705857UnknownPrimary
Comparative Study of Gene-activated Bone Substitute and Autobone in Treatment of Long Bone Nonunions
NCT02307435Early Phase 1UnknownPrimary
Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture
Showing all 4 trials